Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 6/20 | 0.62 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.62 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.62 |
| ▸ | CD69 | Q07108 | 1/20 | 0.52 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.48 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.47 |
| ▸ | AMY2A | P04746 | 2/20 | 0.45 |
| ▸ | FGF1 | P05230 | 1/20 | 0.44 |
| ▸ | FGF2 | P09038 | 1/20 | 0.44 |
| ▸ | VEGFA | P15692 | 1/20 | 0.44 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21180415 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL12197053 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL13541589 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL15849912 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL16312015 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL15176952 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL16301475 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL12356371 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL13541628 | 0.98 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL13541598 | 0.98 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD69CHIA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9937264-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9802996-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9708413-B2 | Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof | GLYTECH, INC. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-9441024-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2016-09-13 | — | — | US | disclosed |
| US-20150306235-A1 | SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME | GLYTECH INC (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | GLYTECH INC (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20140315800-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GLYTECH, INC. (JP) | 2014-10-23 | — | — | US | disclosed |
| US-8765669-B2 | Glycosylated GLP-1 peptide | GLYTECH, INC. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20120264684-A1 | Glycosylated Form of Antigenic GLP-1 Analogue | GLYTECH, INC. (JP) | 2012-10-18 | — | — | US | disclosed |
| US-20120114595-A1 | SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20110313136-A1 | IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING THE SAME | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-12-22 | — | — | US | disclosed |
| US-20110195897-A1 | GLYCOSYLATED GLP-1 PEPTIDE | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313136-A1 | IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING THE SAME | FCGR1A, FCGR2A, FCGR3B | LGALS3 380/4885LGALS8 261/4885LGALS4 123/4885 |
| US-20110195897-A1 | GLYCOSYLATED GLP-1 PEPTIDE | GLP1R, GIPR, IAPP | LGALS3 130/4885LGALS8 64/4885LGALS4 76/4885 |
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR4, SSTR3 | LGALS3 670/4885LGALS8 520/4885LGALS4 830/4885 |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | CD44, CSGALNACT1, UGGT1 | LGALS3 1334/4885LGALS8 398/4885LGALS4 712/4885 |
| US-20120114595-A1 | SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME | SIGLEC7, ENGASE, SIGLEC9 | LGALS3 90/4885LGALS8 47/4885LGALS4 77/4885 |
| US-20150306235-A1 | SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME | SI, ENGASE, DNPEP | LGALS3 1836/4885LGALS8 666/4885LGALS4 1297/4885 |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR3, SSTR4 | LGALS3 609/4885LGALS8 521/4885LGALS4 810/4885 |
| US-20120264684-A1 | Glycosylated Form of Antigenic GLP-1 Analogue | GLP1R, GIPR, IAPP | LGALS3 68/4885LGALS8 44/4885LGALS4 50/4885 |
| US-20140315800-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GIPR, SSTR3, SSTR4 | LGALS3 609/4885LGALS8 521/4885LGALS4 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.